136. First-In-Human Study of NS-065/NCNP-01; The Morpholino Based Antisense Oligonucleotide for Exon 53 Skipping in Duchenne Muscular Dystrophy

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33741-8